Therefore, the present pilot study proposed simultaneous detection of tumor markers (NSE and CEA) by different methods: (1) ELISA kits, (2) the method developed earlier by Stefan-van Staden—which used stochastic sensors, and (3) IHC. The gene discussed is ENO2; the disease is neoplasm.